within Pharmacolibrary.Drugs.ATC.M;

model M01AE14
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 0.0008833333333333333,
    adminDuration  = 600,
    adminMass      = 0.2,
    adminCount     = 1,
    Vd             = 0.00014000000000000001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.022000000000000002,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Dexibuprofen is the S(+)-enantiomer of ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of pain, inflammation, and fever in conditions such as rheumatoid arthritis and osteoarthritis. It is approved and used in Europe and other countries, but not in the United States.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated in healthy adult volunteers after single oral dose administration.</p><h4>References</h4><ol><li>Wenyan Hua, Wenjia Zhou, Mei Su, Quanying Zhang, Shunlin Zong, Meng Wang,Comparative Pharmacokinetics and Safety Studies of Dexibuprofen Injection and a Branded Product Ibuprofen Injection in Healthy Chinese Volunteers.,Clinical pharmacology in drug development,2023<a href='https://pubmed.ncbi.nlm.nih.gov/37140399/'>https://pubmed.ncbi.nlm.nih.gov/37140399/</a></li><li>M Ahsan Shaker, Naveed Akhtar, Muhammad Usman Minhas, Kifayat Ullah Khan, Muhammad Imad-Ud-Din Zangi, Abubakar Munir,Effect of an Al/Mg Hydroxide Antacid and Food on the Pharmacokinetics of Dexibuprofen.,Drug research,2020<a href='https://pubmed.ncbi.nlm.nih.gov/32110819/'>https://pubmed.ncbi.nlm.nih.gov/32110819/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end M01AE14;
